Pay Bill Online
Archives
Dr. Sharma published in British Journal of Ophthalmology
Download the PDF
The Eyes And The Diet
The first step in any good prevention strategy is to undergo a thorough eye exam, said Dr. Ashish Sharma of Retina Consultants of Southwest Florida, a group with five offices in the region. An ophthalmologist can see changes in the eye that a patient may not notice, and that may indicate an underlying disease, Sharma… Read More
I have macular degeneration: What do I do now?
What Is Macular Degeneration Age-related macular degeneration is a common degenerative condition of the retina that can produce ‚Äúlegal blindness,‚Äù usually in retirement age population. About one in 10 individuals in their 50s will display some changes of AMD, and about one in three in their 70s will display AMD changes. There is a definite… Read More
New Macular Degeneration Drug Tested Locally
Patricia Liscinsky of South Fort Myers knew there was something wrong with her vision while driving home from work at a local department store one night. She couldn‚Äôt read the street signs, especially at dusk. Her vision became worse day by day until she finally was no longer able to work nights at all. Then… Read More
18th Annual Vision Research Symposia
ThromboGenics Confirms JETREA US Launch Date of Monday January 14th, 2013
Leuven, Belgium ‚Äì January 4, 2013 ‚Äì ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA¬Æ US launch date of Monday January 14th, 2013. JETREA¬Æ (ocriplasmin) Intravitreal Injection is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion (VMA). The US price… Read More
FDA approves Regeneron’s Eylea for CRVO
Regeneron announced via press release that the U.S. Food and Drug Administration has approved Eylea intravitreal injection for macular edema after central retinal vein occlusion. This is the FDA‚Äôs second approved indication for Eylea (aflibercept). The drug was approved for intravitreal injection for the treatment of neovascular age-related macular degeneration in November 2011. Aflibercept consists… Read More
Can E-readers Help Your Macular Disease Patients?
Easier reading for those with visual deficits June 2011 Current treatments for macular disease are leading to gratifying results, saving much of the severe vision loss that was often unavoidable 10 years ago. Still, despite optimal treatment, many patients end up with a moderate level of visual impairment and complain of difficulty in accessing the… Read More
Area patients recoil from race question
Affordable Care Act requires inquiry September 19, 2011 ‚Äì news-press.com Current treatments for macular disease are leading to gratifying results, saving much of the severe vision loss that was often unavoidable 10 years ago. Still, despite optimal treatment, many patients end up with a moderate level of visual impairment and complain of difficulty in accessing… Read More
FDA approves drug for diabetics
NBC News FORT MYERS ‚Äì AUGUST 10, 2012 Lucentis was approved by the FDA. Doctors are calling it a breakthrough drug for diabetic patients. It helps diabetics who have bleeding and swelling in the back of their eyes. The drug was tested out in a clinical study right here in Fort Myers. NBC-2.com WBBH News… Read More
